为了推进其癌症免疫疗法Multikine®在沙特阿拉伯王国的商业化与分销进程,CEL-SCI公司(CEL-SCI Corp)与沙特本土企业Amarox已达成一项战略合作协议。双方计划于即将到来的Bio 2026国际生物技术大会期间,正式举行签约仪式。
此举标志着Multikine®进入中东关键市场的重要一步。根据协议,双方将整合资源与专长,共同致力于满足沙特地区未被满足的医疗需求,并加速该创新疗法的市场渗透。
为了推进其癌症免疫疗法Multikine®在沙特阿拉伯王国的商业化与分销进程,CEL-SCI公司(CEL-SCI Corp)与沙特本土企业Amarox已达成一项战略合作协议。双方计划于即将到来的Bio 2026国际生物技术大会期间,正式举行签约仪式。
此举标志着Multikine®进入中东关键市场的重要一步。根据协议,双方将整合资源与专长,共同致力于满足沙特地区未被满足的医疗需求,并加速该创新疗法的市场渗透。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.